Abstract:In recent years, single-cell analyses have revealed the heterogeneity of the tumour microenvironment (TME) at the genomic, transcriptomic, and proteomic levels, further improving our understanding of the mechanisms of tumour development. Single-cell RNA sequencing (scRNA-seq) technology allow analysis of the transcriptome at the single-cell level and have unprecedented potential for exploration of the characteristics involved in tumour development and progression. These techniques allow analysis of transcript sequences at higher resolution, thereby increasing our understanding of the diversity of cells found in the tumour microenvironment and how these cells interact in complex tumour tissue. Although scRNA-seq has emerged as an important tool for studying the tumour microenvironment in recent years, it cannot be used to analyse spatial information for cells. In this regard, spatial transcriptomics (ST) approaches allow researchers to understand the functions of individual cells in complex multicellular organisms by understanding their physical location in tissue sections. In particular, in related research on tumour heterogeneity, ST is an excellent complementary approach to scRNA-seq, constituting a new method for further exploration of tumour heterogeneity, and this approach can also provide unprecedented insight into the development of treatments for pancreatic cancer (PC). In this review, based on the methods of scRNA-seq and ST analyses, research progress on the tumour microenvironment and treatment of pancreatic cancer is further explained.

What problem does this paper attempt to address?

The paper aims to explore the advancements in the application of single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics (ST) in the study and treatment of the tumor microenvironment (TME) of pancreatic ductal adenocarcinoma (PDAC). Specifically: 1. **Addressing the complexity of the tumor microenvironment (TME)**: - Single-cell RNA sequencing technology can analyze the transcriptome information of individual cells, revealing the heterogeneity and molecular subtypes of tumor cells. - However, scRNA-seq cannot provide spatial location information of cells, which limits the understanding of cell-cell interactions. 2. **Combining the advantages of scRNA-seq and ST**: - Spatial transcriptomics technology compensates for the lack of spatial information in scRNA-seq. By combining the two methods, it is possible to obtain both the spatial distribution of cells and their gene expression characteristics. - This combination helps to deeply understand the functions and interactions of different cell types in the tumor microenvironment. 3. **Study of cancer-associated fibroblasts (CAFs) in pancreatic cancer**: - The paper identifies various CAF subgroups through scRNA-seq analysis, such as myofibroblastic CAFs (myCAFs), inflammatory CAFs (iCAFs), and antigen-presenting CAFs (apCAFs), and explores the functional differences of these cells in the tumor microenvironment. - Combining ST analysis further reveals the spatial distribution of different CAF subgroups and their relationship with clinical prognosis. 4. **Research on the hypoxic tumor microenvironment**: - Hypoxia is a significant feature of pancreatic cancer, closely related to tumor invasion, metastasis, and drug resistance. - scRNA-seq studies reveal metabolic changes in pancreatic cancer cells under hypoxic conditions, and ST analysis is used to explore the spatial distribution of hypoxia markers (such as HIF-1α) and their relationship with prognosis. 5. **Study of the tumor immune microenvironment (TIME)**: - Pancreatic cancer is highly resistant to immunotherapy, with dysfunctional CD8+ T cells being one of the reasons. - Using scRNA-seq and ST technologies, the spatial distribution of different immune cells in pancreatic cancer and their interactions with cancer cells are revealed, providing new insights for immunotherapy. In summary, this paper combines single-cell RNA sequencing technology and spatial transcriptomics technology to deeply explore the complexity of the pancreatic cancer tumor microenvironment and its impact on treatment, providing new perspectives and strategies for the precise treatment of pancreatic cancer.

Progress of single-cell RNA sequencing combined with spatial transcriptomics in tumour microenvironment and treatment of pancreatic cancer

Spatial transcriptomics in pancreatic cancer: Advances, prospects and challenges

Technique Integration of Single-Cell RNA Sequencing with Spatially Resolved Transcriptomics in the Tumor Microenvironment

Spatial transcriptomics: a new frontier in cancer research

Research progress and the prospect of using single-cell sequencing technology to explore the characteristics of the tumor microenvironment

Single-cell RNA sequencing to map tumor heterogeneity in gastric carcinogenesis paving roads to individualized therapy

Integrating spatial and single-cell transcriptomics reveals tumor heterogeneity and intercellular networks in colorectal cancer

Application of single-cell sequencing to the research of tumor microenvironment

A review of spatial profiling technologies for characterizing the tumor microenvironment in immuno-oncology.

Spatially Resolved Transcriptomics Technology Facilitates Cancer Research

[Advancements in Single-cell RNA Sequencing Technology in the Study of the Tumor Microenvironment in Lung Cancer]

New insights from the single-cell level: Tumor associated macrophages heterogeneity and personalized therapy

The Application of Single-Cell Sequencing in Pancreatic Neoplasm: Analysis, Diagnosis and Treatment

Heterogeneous tumor microenvironment in pancreatic ductal adenocarcinoma: An emerging role of single‐cell analysis

Spatial Transcriptomics Technology in Cancer Research.

Novel insights from spatial transcriptome analysis in solid tumors

Deciphering cell-cell interactions and communication in the tumor microenvironment and unraveling intratumoral genetic heterogeneity via single-cell genomic sequencing

Single-Cell Profiling to Explore Immunological Heterogeneity of Tumor Microenvironment in Breast Cancer

Progress and Clinical Application of Single-Cell Transcriptional Sequencing Technology in Cancer Research

Spatially resolved transcriptomics provide a new method for cancer research

Advances in spatial transcriptomics and its applications in cancer research